American Samoa vs Democratic People's Republic of Korea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

American Samoa
0.4%
in 2024
Democratic People's Republic of Korea
0.4%
in 2024
American Samoa rank
74th
Democratic People's Republic of Korea rank
74th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • American Samoa
  • Democratic People's Republic of Korea
00.10.20.30.40.5201520192024

How they compare

American Samoa currently reports 0.4% against 0.4% in Democratic People's Republic of Korea, a difference of 0.0%.

The two have swapped places 2 times across 10 shared years of data; in 2015 it was Democratic People's Republic of Korea ahead.

American Samoa ranks 74th and Democratic People's Republic of Korea ranks 74th of 246 countries.

American Samoa has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade American Samoa Democratic People's Republic of Korea Difference Ahead
2010s 0.4% 0.4% 0.0% American Samoa
2020s 0.5% 0.3% 0.1% American Samoa

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, American Samoa or Democratic People's Republic of Korea?
American Samoa, at 0.4% against 0.4% in Democratic People's Republic of Korea as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between American Samoa and Democratic People's Republic of Korea?
0.0%, with American Samoa ahead.
How many years of comparable data are there for American Samoa and Democratic People's Republic of Korea?
10 years are reported by both, from 2015 to 2024.
How do American Samoa and Democratic People's Republic of Korea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
American Samoa ranks 74th and Democratic People's Republic of Korea ranks 74th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

American Samoa vs Democratic People's Republic of Korea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 14 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/american-samoa/democratic-people-s-republic-of-korea/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/american-samoa/democratic-people-s-republic-of-korea/">American Samoa vs Democratic People's Republic of Korea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed